Hepatitis B virus regulates Raf1 expression in HepG2.2.15 cells by enhancing its promoter activity

Archives of Virology

Volumn 156, Issue 5, 2011, Pages 869-874

  Tian, Yuanyuan ^a   Hu, Yuan ^a   Wang, Zengchan ^a   Chen, Ke ^a   Zhang, Lei ^a   Wang, Liying ^a   Ren, Min ^a   Huang, Ailong ^a   Tang, Hua ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VIRUS X PROTEIN; RAF PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; BIOSYNTHESIS; CELL LINE; DRUG ANTAGONISM; GENE SILENCING; HEPATITIS B VIRUS; HOST PATHOGEN INTERACTION; HUMAN; LIVER CELL; METABOLISM; PATHOGENICITY; PROMOTER REGION; VIROLOGY;

CELL LINE; GENE SILENCING; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-RAF; TRANS-ACTIVATORS;

HEPATITIS B VIRUS;

EID: 79955156789     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-010-0901-z     Document Type: Article

References (33)

1. Liu Y, Wu F (2010) Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment. Environ Health Perspect 118(6): 818-824.
2. Ahn SH, Park YN, Park JY, Chang HY, Lee JM, Shin JE, Han KH, Park C, Moon YM, Chon CY (2005) Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance. J Hepatol 42: 188-194.
3. Parkin DM, Pisani P, Ferlay J (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80: 827-841.
4. Hildt E, Hofschneider PH (1998) The PreS2 activators of the hepatitis B virus: activators of tumour promoter pathways. Recent Results Cancer Res 154: 315-329.
5. Hildt E, Munz B, Saher G, Reifenberg K, Hofschneider PH (2002) The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice. EMBO J 21(4): 525-535.
6. Hildt E, Saher G, Bruss V, Hofschneider PH (1996) The hepatitis B virus large surface protein (LHBs) is a transcriptional activator. Virology 225(1): 235-239.
7. Benn J, Schneider RJ (1994) Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci USA 91(22): 10350-10354.
8. Bouchard MJ, Schneider RJ (2004) The enigmatic X gene of hepatitis B virus. J Virol 78: 12725-12734.
9. Tarn C, Lee S, Hu Y, Ashendel C, Andrisani OM (2001) Hepatitis B virus X protein differentially activates RAS-RAF-MAPK and JNK pathways in X-transforming versus non-transforming AML12 hepatocytes. J Biol Chem 276(37): 34671-34680.
10. Morrison DK, Kaplan DR, Rapp UR, Roberts TM (1988) Signal transduction from membrane to cytoplasm: growth factors and membrane-bound oncogene products increase Raf-l phosphorylation and associated protein kinase activity. Proc Natl Acad Sci USA 85: 8855-8859.
11. Molina JR, Adjei AA (2006) The Ras/Raf/MAPK pathway. J Thorac Oncol 1(1): 7-9.
12. Chang F, Steelman LS, Lee JT, Shelton JG, Navolanic PM, Blalock WL, Franklin RA, McCubrey JA (2003) Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia 17(7): 1263-1293.
13. Hagemann C, Rapp UR (1999) Isotype-specific functions of Raf kinases. Exp Cell Res 253: 34-46.
14. Franklin RA, McCubrey JA (2000) Kinases: positive and negative regulators of apoptosis. Leukemia 14: 2019-2034.
15. White MK, McCubrey JA (2001) Suppression of apoptosis: role in cell growth and neoplasia. Leukemia 15: 1011-1021.
16. Ito Y, Sasaki Y, Horimoto M, Wada S, Tanaka Y, Kasahara A, Ueki T, Hirano T, Yamamoto H, Fujimoto J, Okamoto E, Hayashi N, Hori M (1998) Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma. Hepatology 27(4): 951-958.
17. Schmidt CM, McKillop IH, Cahill PA, Sitzmann JV (1997) Increased MAPK expression and activity in primary human hepatocellular carcinoma. Biochem Biophys Res Commun 236(1): 54-58.
18. Hwang YH, Choi JY, Kim S, Chung ES, Kim T, Koh SS, Lee B, Bae SH, Kim J, Park YM (2004) Over-expression of c-raf-1 proto-oncogene in liver cirrhosis and hepatocellular carcinoma. Hepatol Res 29(2): 113-121.
19. Yin F, Zhao YJ, Yao SK (2009) Expression of Raf-1 in hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 17(6): 618-622.
20. Chen J, Siddiqui A (2007) Hepatitis B virus X protein stimulates the mitochondrial translocation of Raf-1 via oxidative stress. J Virol 81(12): 6757-6760.
21. Wu KL, Zhang X, Zhang J, Yang Y, Mu YX, Liu M, Lu L, Li Y, Zhu Y, Wu J (2005) Inhibition of Hepatitis B virus gene expression by single and dual small interfering RNA treatment. Virus Res 112(1-2): 100-107.
22. Weinstein IB (2002) Addiction to oncogenes-the Achilles heal of cancer. Science 297(5578): 63-64.
23. Schreck R, Rapp UR (2006) Raf kinases: oncogenesis and drug discovery. Int J Cancer 119(10): 2261-2271.
24. Wang HG, Rapp UR, Reed JC (1996) Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87(4): 629-638.
25. Kondoh N, Wakatsuki T, Hada A, Shuda M, Tanaka K, Arai M, Yamamoto M (2001) Genetic and epigenetic events in human hepatocarcinogenesis. Int J Oncol 18(6): 1271-1278.
26. Sridhar SS, Hedley D, Siu LL (2005) Raf kinase as a target for anticancer therapeutics. Mol Cancer Ther 4(4): 677-685.
27. Yoshida T, Hisamoto T, Akiba J, Koga H, Nakamura K, Tokunaga Y, Hanada S, Kumemura H, Maeyama M, Harada M, Ogata H, Yano H, Kojiro M, Ueno T, Yoshimura A, Sata M (2006) Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors. Oncogene 25(45): 6056-6066.
28. Twu JS, Schloemer RH (1987) Transcriptional trans-activating function of hepatitis B virus. J Virol 61(11): 3448-3453.
29. Yip-Schneider MT, Klein PJ, Wentz SC, Zeni A, Menze A, Schmidt CM (2009) Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells. J Pharmacol Exp Ther 329(3): 1063-1070.
30. Unger T, Shaul Y (1990) The X protein of the hepatitis B virus acts as a transcription factor when targeted to its responsive element. EMBO J 9(6): 1889-1895.
31. Seto E, Mitchell PJ, Yen TS (1989) Transactivation by the hepatitis B virus. X protein depends on AP-2 and other transcription factors. Nature 344: 72-74.
32. Maguire HF, Hoeffler JP, Siddiqui A (1991) HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 252(5007): 842-844.
33. Lee YI, Lee S, Lee Y, Bong YS, Hyun SW, Yoo YD, Kim SJ, Kim YW, Poo HR (1998) The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4. Oncogene 16(18): 2367-2380.